Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study

Ramadas, 2010, Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates, Gut, 59, 1200, 10.1136/gut.2009.202101 Peyrin-Biroulet, 2010, Early Crohn disease: a proposed definition for use in disease-modification trials, Gut, 59, 141, 10.1136/gut.2009.187120 Baert, 2010, Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease, Gastroenterology, 138, 463, 10.1053/j.gastro.2009.09.056 Markowitz, 2000, A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease, Gastroenterology, 119, 895, 10.1053/gast.2000.18144 Sahmoud, 1995, Identifying patients with a high risk of relapse in quiescent Crohn's disease, Gut, 37, 811, 10.1136/gut.37.6.811 Greenstein, 1998, Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms, Gut, 29, 588, 10.1136/gut.29.5.588 Cosnes, 2002, Long-term evolution of disease behaviour of Crohn's disease, Inflamm Bowel Dis, 8, 244, 10.1097/00054725-200207000-00002 Allez, 2002, Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy, Am J Gastroenterol, 97, 947 Louis, 2003, Early development of structuring or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype, Gut, 52, 552, 10.1136/gut.52.4.552 Lichtenstein, 2006, Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease, Am J Gastroenterol, 101, 1030, 10.1111/j.1572-0241.2006.00463.x Beaugerie, 2006, Predictors of Crohn's disease, Gastroenterology, 130, 650, 10.1053/j.gastro.2005.12.019 Wolters, 2006, Phenotype at diagnosis predicts recurrence rates in Crohn's disease, Gut, 55, 1124, 10.1136/gut.2005.084061 Loly, 2008, Predictors of severe Crohn's disease, Scand J Gastroenterol, 43, 948, 10.1080/00365520801957149 Romberg-Camps, 2009, Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease, Am J Gastroenterol, 104, 371, 10.1038/ajg.2008.38 Lakatos, 2009, Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behaviour change in patients with Crohn's disease, World J Gastroenterol, 15, 3504, 10.3748/wjg.15.3504 Rieder, 2010, Serum anti-glycan antibodies predict complicated Crohn's disease behaviour: a cohort study, Inflamm Bowel Dis, 16, 1367, 10.1002/ibd.21179 Lennard-Jones, 1989, Classification of inflammatory bowel disease, Scand J Gastroenterol, 24, 2, 10.3109/00365528909091339 Silverberg, 2005, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can J Gastroenterol, 19, 5, 10.1155/2005/269076 Dignass, 2010, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management, J Crohns Colitis, 4, 28, 10.1016/j.crohns.2009.12.002 Sutherland, 1990, Effect of cigarette smoking on recurrence of Crohn's disease, Gastroenterology, 98, 1123, 10.1016/0016-5085(90)90324-T Kandiel, 2005, Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine, Gut, 54, 1121, 10.1136/gut.2004.049460 Colombel, 2004, The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients, Gastroenterology, 126, 19, 10.1053/j.gastro.2003.10.047 Dotan, 2009, Disease behavior in adult patients: are there predictors for stricture or fistula formation, Dig Dis, 27, 205, 10.1159/000228551 Tavarela, 2001, Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity, Inflamm Bowel Dis, 7, 306, 10.1097/00054725-200111000-00005 Odes, 2007, Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification, J Crohns Colitis, 1, 87, 10.1016/j.crohns.2007.08.004 Munkholm, 1995, Disease activity courses in a regional cohort of Crohn's disease patients, Scand J Gastroenterol, 30, 699, 10.3109/00365529509096316 Vasiliauskas, 1996, Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup, Gastroenterology, 110, 1810, 10.1053/gast.1996.v110.pm8964407 Vasiliauskas, 2000, Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics, Gut, 47, 487, 10.1136/gut.47.4.487 Ferrante, 2007, New serological markers in inflammatory bowel disease are associated with complicated disease behaviour, Gut, 56, 1394, 10.1136/gut.2006.108043 Lichtenstein, 2011, Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviour, Inflamm Bowel Dis, 17, 2488, 10.1002/ibd.21661 Dotan, 2006, Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease, Gastroenterology, 131, 366, 10.1053/j.gastro.2006.04.030